Novo Nordisk A/S - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
NVO New York 2830 www.novonordisk.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Novo Nordisk A/S

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem - Aug 7th, 2026 4:50 pm
Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - Aug 7th, 2026 2:20 pm
Novo Nordisk Stock Rises After GLP-1 Antitrust Win - Aug 7th, 2026 1:52 pm
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound - Aug 7th, 2026 1:48 pm
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - Aug 7th, 2026 11:41 am
Stock Market Rally Powers Ahead; SpaceX, Palantir, Sandisk Are Key Earnings Movers: Weekly Review - Aug 7th, 2026 10:35 am
Lilly and Novo Win a Key GLP-1 Antitrust Fight - Aug 7th, 2026 10:34 am
The Week in Numbers: BP's huge profit, Toyota moves fast - Aug 7th, 2026 4:41 am
Novo Nordisk CEO resets expectations for Wegovy's explosive growth - Aug 6th, 2026 7:03 pm
Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ... - Aug 6th, 2026 5:18 pm
Why Is Everyone Talking About Novo Nordisk? - Aug 6th, 2026 1:20 pm
Amazon Takes Bold Step Beyond Retail - Aug 6th, 2026 11:19 am
Amazon Is Bringing the Weight-Loss Drug Race to Medicare - Aug 6th, 2026 11:04 am
NVO Q2 Earnings Call Centers on Wegovy Pill and Outlook Lift - Aug 6th, 2026 8:00 am
Weight-loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult - Aug 6th, 2026 6:31 am
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates - Aug 6th, 2026 5:30 am
Eli Lilly raises 2026 outlook again as Q2 soars past estimates - Aug 6th, 2026 5:18 am
Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Aug 6th, 2026 5:00 am
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - Aug 6th, 2026 1:18 am
Sector Update: Healthcare Stocks Rise Late Afternoon - Aug 5th, 2026 1:50 pm